Eli Lilly and Company (LLY) will raise its quarterly dividend by 2.0 percent from $0.51 to $0.52 per share in 2017. The increased dividend is payable March 10, 2017, to shareholders of record at of the close of business on February 15, 2017.
Based on an annual dividend of $2.08 and a $67.61 stock price the indicated dividend yield for LLY is 3.1%. The ex-date for the next dividend of 52 cents per share is February 13, 2017.
Eli Lilly and Company is a manufacturer of human pharmaceutical products and animal health products. It’s human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The company's Elanco division develops, manufactures and markets products for both food animals and companion animals. Eli Lilly and Company was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly.